Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nosocomial pneumonia.

Uwe Ostendorf1, Santiago Ewig, Antoni Torres

  • 1Thoraxzentrum Ruhrgebiet, Evangelisches Krankenhaus Herne und Augusta-Kranken-Anstalt Bochum, Bochum, Germany.

Current Opinion in Infectious Diseases
|June 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Angiopathy in Severe COVID-19: Physiological Conclusions Derived from Ventilatory Ratio?

American journal of respiratory and critical care medicine·2020
Same author

Biomarkers in the ICU: less is more? No.

Intensive care medicine·2020
Same author

Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).

European respiratory review : an official journal of the European Respiratory Society·2020
Same author

Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome.

EBioMedicine·2020
Same author

Validation of a Prediction Score for Drug-Resistant Microorganisms in Community-acquired Pneumonia.

Annals of the American Thoracic Society·2020
Same author

Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.

Respiratory medicine·2020
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Recent advances in nosocomial pneumonia management include updated guidelines and improved diagnostic methods for ventilator-associated pneumonia. Beta-lactam monotherapy is preferred over combination therapy to prevent resistance and reduce toxicity.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pulmonology

Background:

  • Nosocomial pneumonia, including ventilator-associated pneumonia (VAP), presents a growing challenge due to increasing multidrug-resistant (MDR) bacteria.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant concern in nosocomial infections.

Purpose of the Study:

  • To review recent advances in the management and prevention of nosocomial pneumonia.
  • To highlight the impact of new American Thoracic Society (ATS) guidelines on clinical practice, particularly outside the USA.

Main Methods:

  • Review of current literature on nosocomial pneumonia management and prevention.
  • Analysis of new ATS guidelines and their implications.
  • Evaluation of diagnostic strategies for VAP.

Related Experiment Videos

  • Assessment of antimicrobial therapy efficacy and resistance patterns.

    • Main Results:

    • The incidence of nosocomial pneumonia caused by MDR bacteria, especially MRSA, is rising.
    • Serial tracheobronchial aspirates can aid in selecting appropriate antimicrobial treatment for VAP, despite diagnostic challenges.
    • Beta-lactam monotherapy demonstrates superior clinical outcomes and better resistance prevention compared to combined beta-lactam and aminoglycoside therapy, with lower nephrotoxicity risk.

    Conclusions:

    • Updated ATS guidelines will significantly influence the clinical approach to nosocomial and healthcare-associated pneumonia.
    • Serial tracheobronchial aspirates are valuable for guiding antimicrobial selection in VAP.
    • Combined beta-lactam and aminoglycoside therapy is likely to be phased out.
    • There is an urgent need for novel therapeutic options for pneumonia caused by nonfermenting bacteria.